These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 34775204

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2.
    Girgis AS, Panda SS, Srour AM, Abdelnaser A, Nasr S, Moatasim Y, Kutkat O, El Taweel A, Kandeil A, Mostafa A, Ali MA, Fawzy NG, Bekheit MS, Shalaby EM, Gigli L, Fayad W, Soliman AAF.
    Bioorg Chem; 2021 Sep; 114():105131. PubMed ID: 34243074
    [Abstract] [Full Text] [Related]

  • 4. Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties.
    Fawazy NG, Panda SS, Mostafa A, Kariuki BM, Bekheit MS, Moatasim Y, Kutkat O, Fayad W, El-Manawaty MA, Soliman AAF, El-Shiekh RA, Srour AM, Barghash RF, Girgis AS.
    Sci Rep; 2022 Aug 16; 12(1):13880. PubMed ID: 35974029
    [Abstract] [Full Text] [Related]

  • 5. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
    Mourad AAE, Farouk NA, El-Sayed EH, Mahdy ARE.
    Life Sci; 2021 Jul 15; 277():119531. PubMed ID: 33887348
    [Abstract] [Full Text] [Related]

  • 6. Discovery of novel rigid analogs of 2-naphthol with potent anticancer activity through multi-target topoisomerase I & II and tyrosine kinase receptor EGFR & VEGFR-2 inhibition mechanism.
    El-Mawgoud HKA, Fouda AM, El-Nassag MAA, Elhenawy AA, Alshahrani MY, El-Agrody AM.
    Chem Biol Interact; 2022 Mar 01; 355():109838. PubMed ID: 35123995
    [Abstract] [Full Text] [Related]

  • 7. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM, AboulWafa OM, Baghdadi HH, Abd El Razik HA, Sedra SMY, Shamaa MM.
    Bioorg Chem; 2021 Oct 01; 115():105208. PubMed ID: 34365057
    [Abstract] [Full Text] [Related]

  • 8. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
    Abd El-Meguid EA, Naglah AM, Moustafa GO, Awad HM, El Kerdawy AM.
    Bioorg Med Chem Lett; 2022 Feb 15; 58():128529. PubMed ID: 35007724
    [Abstract] [Full Text] [Related]

  • 9. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
    Vannini F, Chattopadhyay M, Kodela R, Rao PPN, Kashfi K.
    Redox Biol; 2015 Dec 15; 6():318-325. PubMed ID: 26319435
    [Abstract] [Full Text] [Related]

  • 10. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA, Sakr H, Ayyad RRA, El-Adl K, Ali MM, Khedr F.
    Anticancer Agents Med Chem; 2018 Dec 15; 18(8):1184-1196. PubMed ID: 29651967
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation.
    Warda ET, Shehata IA, El-Ashmawy MB, El-Gohary NS.
    Bioorg Med Chem; 2020 Nov 01; 28(21):115674. PubMed ID: 33065442
    [Abstract] [Full Text] [Related]

  • 13. Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile.
    Mghwary AE, Gedawy EM, Kamal AM, Abuel-Maaty SM.
    J Enzyme Inhib Med Chem; 2019 Dec 01; 34(1):838-852. PubMed ID: 30919701
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, human topoisomerase IIα inhibitory properties and molecular modeling studies of anti-proliferative curcumin mimics.
    Fawzy NG, Panda SS, Fayad W, Shalaby EM, Srour AM, Girgis AS.
    RSC Adv; 2019 Oct 18; 9(58):33761-33774. PubMed ID: 35528906
    [Abstract] [Full Text] [Related]

  • 15. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents.
    Pathak A, Pandey V, Raj Pokharel Y, Devaraji V, Ali A, Haider K, Saad S, Dewangan RP, Siddiqui N, Shahar Yar M.
    Bioorg Chem; 2021 Nov 18; 116():105358. PubMed ID: 34544029
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK, Batran RZ, Elseginy SA, Ali MM, Mahmoud AE.
    Bioorg Chem; 2019 Apr 18; 85():253-273. PubMed ID: 30641320
    [Abstract] [Full Text] [Related]

  • 17. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA, Nour MS, Salem MA, Arafa RK.
    Eur J Med Chem; 2019 Dec 01; 183():111693. PubMed ID: 31539778
    [Abstract] [Full Text] [Related]

  • 18. New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitors.
    Alamshany ZM, Tashkandi NY, Othman IMM, Anwar MM, Nossier ES.
    Bioorg Chem; 2022 Oct 01; 127():105964. PubMed ID: 35759881
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M).
    Shaheen MA, El-Emam AA, El-Gohary NS.
    Bioorg Chem; 2020 Dec 01; 105():104274. PubMed ID: 33339080
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA, Abdel-Mohsen HT, El Kerdawy AM, Ragab FAF, Ali MM, Abu-Bakr SM, Girgis AS, El Diwani HI.
    Eur J Med Chem; 2017 Aug 18; 136():315-329. PubMed ID: 28505536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.